These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3521613)

  • 61. Susceptibility to UVB light in cultured keratinocytes of cutaneous lupus erythematosus.
    Furukawa F; Kanauchi H; Imamura S
    Dermatology; 1994; 189 Suppl 1():18-23. PubMed ID: 8049557
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neonatal lupus and the pathogenesis of cutaneous lupus.
    Lee LA; Norris DA; Weston WL
    Pediatr Dermatol; 1986 Dec; 3(6):491-7. PubMed ID: 3494240
    [No Abstract]   [Full Text] [Related]  

  • 63. Direct cutaneous immunofluorescent test in lupus erythematosus.
    Nesbitt LT; Gum OB
    South Med J; 1973 Sep; 66(9):991-7. PubMed ID: 4126199
    [No Abstract]   [Full Text] [Related]  

  • 64. Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjögren's syndrome: a prospective study.
    Praprotnik S; Bozic B; Kveder T; Rozman B
    Clin Exp Rheumatol; 1999; 17(1):63-8. PubMed ID: 10084034
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
    Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
    J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of IgG subclass autoantibodies in patients with systemic lupus erythematosus and subacute cutaneous lupus erythematosus.
    Elenitsas R; Abell E; Lee YY; Huang J; Deng JS
    J Dermatol Sci; 1990 May; 1(3):207-15. PubMed ID: 2085508
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Localization of Ro (SS-A) antigen in the cardiac conduction system.
    Deng JS; Bair LW; Shen-Schwarz S; Ramsey-Goldman R; Medsger T
    Arthritis Rheum; 1987 Nov; 30(11):1232-8. PubMed ID: 3318846
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A serological marker for neonatal lupus erythematosus.
    Weston WL; Harmon C; Peebles C; Manchester D; Franco HL; Huff JC; Norris DA
    Br J Dermatol; 1982 Oct; 107(4):377-82. PubMed ID: 7126448
    [No Abstract]   [Full Text] [Related]  

  • 69. Development of squamous cell carcinoma in chronic discoid lupus erythematosus: a report of two patients with anti-Ro/SSA antibodies.
    Miyagawa S; Minowa R; Yamashina Y; Ohi H; Shira T
    Lupus; 1996 Dec; 5(6):630-2. PubMed ID: 9116710
    [No Abstract]   [Full Text] [Related]  

  • 70. Anti-Ro autoantibody with cross-reactive binding to the heavy chain of immunoglobulin G.
    Mamula MJ; Harley JB
    Yale J Biol Med; 1992; 65(4):277-87. PubMed ID: 1290272
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ro (SS-A) antibody and antigen in a patient with congenital complete heart block.
    Harley JB; Kaine JL; Fox OF; Reichlin M; Gruber B
    Arthritis Rheum; 1985 Dec; 28(12):1321-5. PubMed ID: 3878714
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of La and Ro antigens with intracellular structures in HEp-2 carcinoma cells.
    Bachmann M; Mayet WJ; Schröder HC; Pfeifer K; Meyer zum Büschenfelde KH; Müller WE
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7770-4. PubMed ID: 2429318
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Prosser-White oration 1983. Connective tissue disease and the skin.
    Hughes GR
    Clin Exp Dermatol; 1984 Nov; 9(6):535-44. PubMed ID: 6437711
    [No Abstract]   [Full Text] [Related]  

  • 74. Neonatal lupus syndrome.
    Olson NY; Lindsley CB
    Am J Dis Child; 1987 Aug; 141(8):908-10. PubMed ID: 3307387
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The use of antibody to C5b-9 in the subclassification of lupus erythematosus.
    Magro CM; Crowson AN; Harrist TJ
    Br J Dermatol; 1996 May; 134(5):855-62. PubMed ID: 8736325
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A monoclonal Ro-antibody and the serum of a Ro-positive patient with subacute cutaneous lupus erythematosus (SCLE) react with basal layers of human epidermis.
    Mayet WJ; Bachmann M; Pfeifer K; Schröder HC; Müller WE; Gudat W; Korting GW; Meyer zum Büschenfelde KH
    Eur J Clin Invest; 1988 Oct; 18(5):465-71. PubMed ID: 3147897
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro(SSA) proteins.
    McCauliffe DP; Yin H; Wang LX; Lucas L
    J Rheumatol; 1994 Jun; 21(6):1073-80. PubMed ID: 7523671
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus.
    Silverman E; Mamula M; Hardin JA; Laxer R
    J Rheumatol; 1991 Jan; 18(1):120-4. PubMed ID: 2023181
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Production and characterization of human hybridoma monoclonal anti-Sm and anti-U1RNP antibodies spontaneously produced from normal human lymphocytes.
    Carruthers CJ; Bell DA
    J Autoimmun; 1992 Aug; 5(4):527-44. PubMed ID: 1418291
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease.
    Provost TT; Watson R; Simmons-O'Brien E
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):147-69; quiz 170-2. PubMed ID: 8708014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.